Cold sore virus weaponized to fight breast cancer
NCT ID NCT02779855
Summary
This study tested whether injecting a specially modified cold sore virus directly into breast tumors during chemotherapy before surgery could help eliminate cancer more effectively. The virus is designed to attack cancer cells and may help the patient's own immune system fight the tumor. Researchers wanted to see if this approach, already approved for skin cancer, could benefit women with a hard-to-treat type of breast cancer.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
H. Lee Moffitt Cancer Center and Research Institute
Tampa, Florida, 33612, United States
Conditions
Explore the condition pages connected to this study.